About Atacama Therapeutics
Atacama Therapeutics is a private company based in Wellesley, Massachusetts. It has reported $830,000 raised in one offering on Form D since May 2024. Its chief executive is Joseph Baron.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Apr 26, 2024 | May 6, 2024amended May 7, 2024 | $830,000of $4.7M target | 16 | $51,875 | EquityRule 506(b) | Form D/A ↗1 earlier filing |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Atacama Therapeutics's Form D filed May 7, 2024.
JB
Joseph Baron
Chief Executive Officer and director
JR
Jonathan Reis
Director